German drugmaker BioNTech is enrolling patients in a clinical trial to test its mRNA vaccine for colon cancer relapse.
How a new mRNA vaccine could use the body’s immune system to fight cancer
Posted in biotech/medical
Posted in biotech/medical
German drugmaker BioNTech is enrolling patients in a clinical trial to test its mRNA vaccine for colon cancer relapse.